Common polymorphisms in antioxidant genes are associated with diabetic nephropathy in Type 2 diabetes patients

Personalized Medicine

Volumn 12, Issue 3, 2015, Pages 187-198

  Klen, Jasna ^a   Goričar, Katja ^b   Janež, Andrej ^c   Dolžan, Vita ^b  

^a Trbovlje General Hospital   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

antioxidative enzymes; CAT; genetic polymorphism; GSTP1; oxidative stress; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; CATALASE; CHOLESTEROL; GCLC ENZYME; GCLM ENZYME; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE SUPEROXIDE DISMUTASE; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMINURIA; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; END STAGE RENAL DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

EID: 84930701251     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.14.86     Document Type: Article

References (51)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131), 837-853 (1998
2. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10 year follow-up of intensive glucose control in Type 2 diabetes. N. Engl. J. Med. 359(15), 1577-1589 (2008
3. Park J, Lertdumrongluk P, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr. Diab. Rep. 12(4), 432-439 (2012
4. Ritz E. Clinical manifestations and natural history of diabetic kidney disease. Med. Clin. North Am. 97(1), 19-29 (2013
5. Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in Type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in Type 2 diabetes. Arch. Intern. Med. 172(10), 761-769 (2012
6. Badal SS, Danesh FR. New insights into molecular mechanisms of diabetic kidney disease. Am. J. Kidney Dis. 63(2 Suppl. 2), s63-s83 (2014
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865), 813-820 (2001
8. Sasaki S, Inoguchi T. The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diab. Metab. J. 36(4), 255-261 (2012
9. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. 85(8), 2970-2973 (2000
10. Satirapoj B. Nephropathy in diabetes. Adv. Exp. Med. Biol. 771, 107-122 (2012
11. Stanton RC. Oxidative stress and diabetic kidney disease. Curr. Diab. Rep. 11(4), 330-336 (2011
12. Sun YM, Su Y, Li J, Wang LF. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem. Biophys. Res. Commun. 433(4), 359-361 (2013
13. Crawford A, Fassett RG, Geraghty DP et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 501(2), 89-103 (2012
14. Forsberg L, De Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch. Biochem. Biophys. 389(1), 84-93 (2001
15. Tang ST, Wang CJ, Tang HQ, Zhang Q, Wang Y. Evaluation of glutathione-S-transferase genetic variants affecting Type 2 diabetes susceptibility: a meta-analysis. Gene 530(2), 301-308 (2013
16. Zhang J, Liu H, Yan H, Huang G, Wang B. Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: a meta-analysis. Gene 518(2), 405-411 (2013
17. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc. Diabetol. 4(1), 5 (2005
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35 (Suppl. 1), s64-s71 (2012) .
19. WHO/IDF. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation (2006
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann. Intern. Med. 130(6), 461-470 (1999
21. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes. Kidney Int. 67(6), 2089-2100 (2005
22. Klen J, Gori?ar K, Janež A, Dolžan V. The role of genetic factors and kidney and liver function in glycemic control in Type 2 diabetes patients on long-term metformin and sulphonylurea cotreatment. BioMed Res. Int. 2014, 934729 (2014
23. Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V. Genetic polymorphisms of glutathione-S-transferases and disease activity of rheumatoid arthritis. Clin. Exp. Rheumatol. 27(2), 229-236 (2009
24. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione-S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6(2), 187-191 (1996
25. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with Type 1 diabetes and diabetic nephropathy. Diabetes 52(3), 846-851 (2003
26. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med. Genet. 9, 30 (2008
27. Panduru NM, Mota E, Mota M, Cimponeriu D, Serafinceanu C, Cheta DM. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and Type 1 diabetes. Rom. J. Intern. Med. 48(1), 81-88 (2010
28. Neves AL, Mohammedi K, Emery N et al. Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in Type 2 diabetic subjects. Mol. Genet. Metab. 106(3), 359-365 (2012
29. Gysin R, Kraftsik R, Boulat O et al. Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia. Antioxid. Redox. Signal. 15(7), 2003-2010 (2011
30. Willis AS, Freeman ML, Summar SR et al. Ethnic diversity in a critical gene responsible for glutathione synthesis. Free Radic. Biol. Med. 34(1), 72-76 (2003
31. Koide S, Kugiyama K, Sugiyama S et al. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J. Am. Coll. Cardiol. 41(4), 539-545 (2003
32. Nakamura S, Kugiyama K, Sugiyama S et al. Polymorphism in the 5-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 105(25), 2968-2973 (2002
33. Katakami N, Kaneto H, Matsuoka TA et al. Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese Type 2 diabetic patients. Atherosclerosis 212(2), 534-538 (2010
34. Ramprasath T, Murugan PS, Kalaiarasan E, Gomathi P, Rathinavel A, Selvam GS. Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H: Quinone Oxidoreductase 1 (NQO1) variants and their association of CAD in patients with Type 2 diabetes. Mol. Cell Biochem. 361(1-2), 143-150 (2012
35. Amer MA, Ghattas MH, Abo-Elmatty DM, Abou-El-Ela SH. Evaluation of glutathione S-transferase P1 genetic variants affecting Type 2 diabetes susceptibility and glycemic control. Arch. Med. Sci. 8(4), 631-636 (2012
36. Moasser E, Kazemi-Nezhad SR, Saadat M, Azarpira N. Study of the association between glutathione S-transferase (GSTM1, GSTT1, GSTP1) polymorphisms with Type 2 diabetes mellitus in southern of Iran. Mol. Biol. Rep. 39(12), 10187-10192 (2012
37. Datta SK, Kumar V, Pathak R et al. Association of glutathione-S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren. Fail. 32(10), 1189-1195 (2010
38. Pinheiro DS, Rocha Filho CR, Mundim CA et al. Evaluation of glutathione-S-transferase GSTM1 and GSTT1 deletion polymorphisms on Type 2 diabetes mellitus risk. PLoS ONE 8(10), e76262 (2013
39. Cilensek I, Mankoc S, Petrovic MG, Petrovic D. GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with Type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy. Dis. Markers 32(2), 93-99 (2012
40. Kariz S, Nikolajevic Starcevic J, Petrovic D. Association of manganese superoxide dismutase and glutathione-Stransferases genotypes with myocardial infarction in patients with Type 2 diabetes mellitus. Diab. Res. Clin. Pract. 98(1), 144-150 (2012
41. Santl Letonja M, Letonja M, Ikolajevic-Starcevic JN, Petrovic D. Association of manganese superoxide dismutase and glutathione-S-transferases genotypes with carotid atherosclerosis in patients with diabetes mellitus Type 2. Int. Angiol. 31(1), 33-41 (2012
42. Vidan-Jeras B, Jurca B, Dolan V, Jeras M, Breskvar K, Bohinjec M. Slovenian Caucasian normal. In: HLA 1998. Terasaki PI, Gjertson DW (Eds). American Society for Histocompatibility and Immunogenetics, Kansas, USA (1998
43. Campos C. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad. Med. 124(6), 90-97 (2012
44. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19(3), 257-267 (1996
45. Lyons TJ, Basu A. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl. Res. 159(4), 303-312 (2012
46. Gnudi L. Cellular and molecular mechanisms of diabetic glomerulopathy. Nephrol. Dial. Transplant. 27(7), 2642- 2649 (2012
47. Battisti WP, Palmisano J, Keane WE. Dyslipidemia in patients with Type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease. Clin. Chem. Lab. Med. 41(9), 1174-1181 (2003
48. Parati G, Bilo G, Ochoa JE. Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies. Diabetes Care 34(Suppl. 2), S297-S303 (2011
49. Scarpioni R, Ricardi M, Albertazzi V, Melfa L. Treatment of dyslipidemia in chronic kidney disease: effectiveness and safety of statins. World. J. Nephrol. 1(6), 184-194 (2012
50. Jardine MJ, Hata J, Woodward M et al. Prediction of kidneyrelated outcomes in patients with Type 2 diabetes. Am. J. Kidney Dis. 60(5), 770-778 (2012
51. Jun M, Venkataraman V, Razavian M et al. Antioxidants for chronic kidney disease. Cochrane Database Syst. Rev. 10, CD008176 (2012